The Mariners are hoping for a healthy season from Matt Brash to strengthen their bullpen, which has been a focus after non-tendering JT Chargois and Austin Voth.

Matt Brash is expected to return from Tommy John surgery ahead of schedule in April or May, providing a potential boost to the Mariners' bullpen as they look to fill gaps left by recent departures.

Matt Brash is recovering ahead of schedule from Tommy John surgery and is expected to return by late April. His presence is anticipated to bolster the Mariners' bullpen significantly, given his impressive 2023 performance where he recorded a 3.06 ERA and led the league with 78 appearances. Brash is known for his powerful fastball and effective slider, making him a key asset for the team's pitching depth.

Matt Brash has successfully transitioned to a bullpen role in the major leagues, showcasing the Mariners' effective player development system. His performance adds depth to the team's pitching roster, further emphasizing the organization's ability to cultivate talent.

Matt Brash is a key reliever for the Mariners who underwent Tommy John surgery, causing him to miss the entire 2023 season. Despite this setback, there is optimism surrounding his recovery, as he is reportedly ahead of schedule and could return to the bullpen by late April 2025. Brash, known for his triple-digit fastball and wicked slider, had an impressive 2023 season with a 3.06 ERA and led the league in appearances. His return is seen as crucial for providing stability to the bullpen.